Search

everythinglearnresearchcommunity

for

Search:↓

Neoplasms hide in hair follicles to avoid the immune system.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

Activating Nrf2 in skin cells causes skin disease similar to chloracne in mice.

Vitamins A, B, C, and D are important for skin health and are being explored for new uses, but more research is needed to confirm their effectiveness.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Getting the right amount of selenium is important for health; too little can cause disease, and too much can lead to toxicity.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

More people were diagnosed with certain skin diseases and sexually transmitted diseases in 2014 compared to 2003 in a Brazilian public institution.

Grape seed extract may safely and effectively help prevent lung cancer.

Scalp cooling significantly reduces chemotherapy-induced hair loss.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

PCOS may increase the risk of certain cancers.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Endocrine therapies for cancer significantly increase the risk of hair loss.